Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Cited by (1,093)

Items 701–800 of 1,093

1. Diagnosing and managing diabetes in HIV-infected patients: current concepts
   Monroe, A. K., Glesby, M. J., Brown, T. T. · 2015 · Clinical Infectious Diseases
2. Type 2 Diabetes
   Sandeep S. Vijan · 2015 · Annals of Internal Medicine
3. Sitagliptin
   Sohita Dhillon · 2010 · Drugs
4. Diabetes and cancer I: risk, survival, and implications for screening
   Adedayo A. Onitilo, Jessica Marie Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A.R. Doi · 2012 · Cancer Causes & Control
5. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates
   Herbert Franz Jelinek, Wael Mohammed Osman, Ahsan Habib Khandoker, Kinda A. Khalaf, Sungmun Lee, Wael A. Almahmeed, Habiba S. AlSafar · 2017 · BMJ Open Diabetes Research & Care
6. Diabetic Cardiomyopathy
   Shishir Murarka, Mohammad Reza Movahed · 2010 · Journal of Cardiac Failure
7. Anesthetic Implications of Concurrent Diseases
   Michael F. Roizen, Lee A. Fleisher · 2010 · Elsevier eBooks
8. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
   Omar S. Ahmad, John A. Morris, Muhammad Hussain Mujammami, Vincenzo Forgetta, Aaron Leong, Rui Li, Maxime Turgeon, Celia M.T. Greenwood, George Thanassoulis, James B. Meigs et al. · 2015 · Nature Communications
9. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?
   Christopher Saunders, Christopher D. Byrne, Bruce Guthrie, Robert S. Lindsay, John A. McKnight, Sam Philip, Naveed A. Sattar, Jeremy J. Walker, Sarah H. Wild · 2012 · Diabetic Medicine
10. New Drugs for Type 2 Diabetes Mellitus
    Andrew J. Krentz, Mayank Patel, Clifford J. Bailey · 2008 · Drugs
11. Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
    Saket Gupta, Ashwini Maratha, Jakub Siednienko, Anandan Natarajan, Thusitha Gajanayake, Shu Hoashi, Sinéad M. Miggin · 2017 · Scientific Reports
12. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
    Sheyu Li, Per Olav Vandvik, Lyubov Lytvyn, Gordon Henry Guyatt, Suetonia C. Palmer, René Rodríguez‐Gutiérrez, Farid Foroutan, Thomas Agoritsas, Reed Alexander Cunningham Siemieniuk, Michael W. Walsh et al. · 2021 · BMJ
13. 9. Microvascular Complications and Foot Care
    American Diabetes Association · 2014 · Diabetes Care
14. A study of the natural history of diabetic kidney disease (DKD)
    Nagi Altemtam, J. Russell, Meguid El Nahas · 2011 · Nephrology Dialysis Transplantation
15. Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
    M Hanefeld, Brian M. Frier, Frank Pistrosch · 2016 · Diabetes Care
16. Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
    Mary E. Herman, James Henry O’Keefe, David S.H. Bell, Stanley S. Schwartz · 2017 · Progress in Cardiovascular Diseases
17. Documento de información y consenso para la detección y manejo de la enfermedad renal crónica
    Rafael García Maset, Jordi Bover, J. Segura, Marian Goicoechea Diezhandino, Jesús Cebollada del Hoyo, Javier Escalada San Martín, Lorenzo Fácila, Javier Gamarra, José Antonio García‐Donaire, Lisardo García Matarin et al. · 2021 · Nefrología
18. Canadian Society of Nephrology Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management
    Ayub Akbari, Catherine M. Clase, Phil Acott, Marisa Battistella, Aminu K. Bello, Patrick Feltmate, Allan K. Grill, Meena Karsanji, Paul V. J. Komenda, François Madore et al. · 2014 · American Journal of Kidney Diseases
19. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits
    Jens Oellgaard, Peter Gæde, Peter R Rossing, Frederik Persson, Hans‐Henrik Parving, Oluf Borbye Pedersen · 2017 · Kidney International
20. Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
    Mark O. Goodarzi, Jerome I. Rotter · 2020 · Circulation Research
21. Latin American guidelines on hypertension*
    Ramiro Ariel Sanchez, Miryam Ayala, Hugo P. Baglivo, Carlos Velazquez, Guillermo Burlando, Oswaldo Kohlmann, Jorge Jimenez, Patricio A López-Jaramillo, Ayrton Brandao, Gloría Valdés et al. · 2009 · Journal of Hypertension
22. The Relationship between Retinal Microvascular Abnormalities and Coronary Heart Disease: A Review
    Benjamin R. McClintic, Jedediah I. McClintic, John D. Bisognano, Robert Block · 2010 · The American Journal of Medicine
23. Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients
    Christiane Drechsler, Vera Krane, Eberhard Ritz, Winfried März, Christoph Wanner · 2009 · Circulation
24. Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease
    Rikki M. Tanner, Todd M. Brown, Paul Muntner · 2012 · Current Hypertension Reports
25. A Summary of the ADVANCE Trial
    Simon R. Heller, on behalf of the ADVANCE Collaborative Group · 2009 · Diabetes Care
26. Do sulphonylureas still have a place in clinical practice?
    Khunti, Kamlesh, Chatterjee, Sudesna, Gerstein, Hertzel C, Zoungas, Sophia, Davies, Melanie J · 2018 · The Lancet Diabetes & Endocrinology
27. Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment
    Ting, Ru-Dee, Keech, Anthony C., Drury, Paul L., Donoghoe, Mark W., Hedley, John, Jenkins, Alicia J., Davis, Timothy M.E., Lehto, Seppo, Celermajer, David, Simes, R. John et al. · 2012 · Diabetes Care
28. Effect of ‘activity monitor-based’ counseling on physical activity and health-related outcomes in patients with chronic diseases: A systematic review and meta-analysis
    Vaes, Anouk W., Cheung, Amy, Atakhorrami, Maryam, Groenen, Miriam T. J., Amft, Oliver, Franssen, Frits M. E., Wouters, Emiel F. M., Spruit, Martijn A. · 2013 · Annals of Medicine
29. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Anil Pareek, Nitin Chandurkar, Kumar Naidu · 2016 · New England Journal of Medicine
30. Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes: The LANCET Randomized Trial
    Pradhan, Aruna D., Everett, Brendan M., Cook, Nancy R., Rifai, Nader, Ridker, Paul M · 2009 · JAMA
31. SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory
    Paneni, Francesco, Volpe, Massimo, Lüscher, Thomas Felix, Cosentino, Francesco · 2013 · Diabetes
32. Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis
    Housden, Laura, Wong, Sabrina T., Dawes, Martin · 2013 · Canadian Medical Association Journal
33. Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes
    Kamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, Sophia Zoungas, Bryan Williams, Liu Lisheng, Anthony Rodgers, Giuseppe Mancia, Bruce Charles Neal, Stephen B. Harrap et al. · 2016 · Diabetes Care
34. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
    Keizo Kanasaki · 2018 · Clinical Science
35. Diabetes in Older People
    Graydon S. Meneilly, Aileen Knip, David B. Miller, Diana Sherifali, Daniel Tessier, Afshan Zahedi · 2018 · Canadian Journal of Diabetes
36. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus
    Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G. D., Ninomiya, T. et al. · 2012 · Diabetologia
37. Diabetic Cardiomyopathy
    Joel D. Schilling, Douglas L. Mann · 2012 · Heart Failure Clinics
38. Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus
    Brendan M. Everett, Nancy R. Cook, Maria Chiara Magnone, María Bobadilla, Eunjung Kim, Nader Rifai, Paul M. Ridker, Aruna D. Pradhan · 2011 · Circulation
39. Lipids and lipid management in diabetes
    Mamta Jaiswal, Ashley Schinske, Rodica Pop‐Busui · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
40. Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
    William B. White, Richard E. Pratley, Penny R. Fleck, Melvin Munsaka, Michie Hisada, C. Wilson, Venu Menon · 2013 · Diabetes Obesity and Metabolism
41. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
    on behalf of the ADVANCE Collaborative Group, Kamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, Sophia Zoungas, Stephen Colagiuri, Pavel Hamet, Stephen B. Harrap, Neil R Poulter, David Richard Matthews et al. · 2016 · Cardiovascular Diabetology
42. Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis
    John Peter Mitsios, Elif Ilhan Ekinci, Gregory Peter Mitsios, Leonid P. Churilov, Vincent Thijs · 2018 · Journal of the American Heart Association
43. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease
    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John Dean Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan A. Fowler, Gary H. Friday et al. · 2011 · Circulation
44. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
    Mohammedi, Kamel, Woodward, Mark, Marre, Michel, Colagiuri, Stephen, Cooper, Mark, Harrap, Stephen, Mancia, Giuseppe, Poulter, Neil, Williams, Bryan, Zoungas, Sophia et al. · 2017 · Cardiovascular Diabetology
45. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications
    Maíra Viégas, Christiane Costa, Arthur Soares Lopes, Luiz Griz, Maria Antonieta Medeiro, Francisco Alfredo Farias Bandeira · 2011 · Journal of Diabetes and its Complications
46. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery
    D. Cummings, R. Cohen · 2014 · The Lancet Diabetes and Endocrinology
47. Oral Disease in Relation to Future Risk of Dementia and Cognitive Decline: Prospective Cohort Study Based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (Advance) Trial
    George David Batty, Q. Li, Rachel Huxley, Sophia Zoungas, B.-A. Taylor, Bruce Charles Neal, Bastiaan E. de Galan, Mark Woodward, Stephen B. Harrap, Stephen Colagiuri et al. · 2011 · European Psychiatry
48. A Unified Pathophysiological Construct of Diabetes and its Complications
    Stanley S. Schwartz, Solomon Epstein, Barbara E. Corkey, Struan F.A. Grant, James R. Gavin, Richard B. Aguilar, Mary E. Herman · 2017 · Trends in Endocrinology and Metabolism
49. Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study
    Edward J. Boyko, Amber D. Seelig, Jessie H. Ahroni · 2018 · Diabetes Care
50. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus—review and meta-analysis
    Amanda Adler, Sebhat A. Erqou, T. A. S. Lima, Andrew H.N. Robinson · 2010 · Diabetologia
51. Assessing the Cardiovascular Safety of Diabetes Therapies
    Allison B. Goldfine · 2008 · New England Journal of Medicine
52. Diabetic retinopathy – Biomolecules and multiple pathophysiology
    Haseeb Ahsan · 2014 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
53. A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)
    Vikas Pai, Arunachalam Paneerselvam, Satinath Mukhopadhyay, Anil Kumar Bhansali, Dinesh Kamath, V Shankar, Dhiraj Gambhire, Rajendrakumar H. Jani, Shashank Joshi, Pankaj Patel · 2014 · Journal of Diabetes Science and Technology
54. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in E urope and the USA
    Dı́dac Mauricio, Luigi Meneghini, Jochen Seufert, Laura Liao, Hongwei Wang, Liyue Tong, Anna M. G. Cali, Péter Stella, Paulo Carita, Kamlesh K. Khunti · 2017 · Diabetes Obesity and Metabolism
55. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
    Paul I. Welsh, Naomi Rankin, Qiang Li, Patrick Barry Mark, Peter Würtz, Mika Ala‐Korpela, Michel Marre, Neil R Poulter, Pavel Hamet, John Philip Chalmers et al. · 2018 · Diabetologia
56. Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late
    Roche, Madonna M., Wang, Peizhong Peter · 2013 · Diabetes Care
57. Beyond HbA1c: comparing glycemic variability and glycemic indices in predicting hypoglycemia in type 1 and type 2 diabetes
    Rama Chandran, Suresh, Tay, Wei Lin, Lye, Weng Kit, Lim, Lee Ling, Ratnasingam, Jeyakantha, Tan, Alexander Tong Boon, S.L. Gardner, Daphne · 2018 · Diabetes Technology & Therapeutics
58. Effects of Dapagliflozin on Cardiovascular Risk Factors
    Agata Ptaszynska, Elise Hardy, EVA K. JOHNSSON, Shamik J. Parikh, James F. List · 2013 · Postgraduate Medicine
59. The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
    Paolo Pozzilli, Richard David Leslie, Juliana C.N. Chan, R De Fronzo, L. Monnier, Itamar Raz, Stefano Del Prato · 2010 · Diabetes/Metabolism Research and Reviews
60. Lowering the Triglyceride/High-Density Lipoprotein Cholesterol Ratio Is Associated With the Beneficial Impact of Pioglitazone on Progression of Coronary Atherosclerosis in Diabetic Patients
    Stephen James Nicholls, Emin Murat Tuzcu, Kathy Wolski, Özgür Bayturan, Andrea Lavoie, Kiyoko Uno, Stuart Kupfer, Alfonso Pérez, Richard W. Nesto, Steven E. Nissen · 2011 · Journal of the American College of Cardiology
61. Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects
    Hassan Kahal, Anna Halama, Ahmed A. Aburima, Aditya Mukund Bhagwat, Alexandra E. Butler, Johannes Graumann, Karsten Suhre, Thozhukat Sathyapalan, Stephen Lawrence Atkin · 2020 · Scientific Reports
62. Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimerʼs Disease
    Garth J. S. Cooper · 2011 · Drugs
63. Exercise-related hypoglycemia in diabetes mellitus
    Younk, Lisa M, Mikeladze, Maia, Tate, Donna, Davis, Stephen N · 2011 · Expert Review of Endocrinology & Metabolism
64. Targets for Glycemic Control
    Imran, S. Ali, Agarwal, Gina, Bajaj, Harpreet S., Ross, Stuart · 2018 · Canadian Journal of Diabetes
65. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown, Adrian, Guess, Nicola, Dornhorst, Anne, Taheri, Shahrad, Frost, Gary · 2017 · Diabetes, Obesity and Metabolism
66. Comparison of insulin detemir and insulin glargine using a basal‐bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
    Philip Raskin, Titus Gylvin, Wayne Weng, LOUIS B. CHAYKIN · 2009 · Diabetes/Metabolism Research and Reviews
67. The Treatment of Type 2 Diabetes
    Andreas F. H. Pfeiffer, Harald H. Klein · 2014 · Deutsches Ärzteblatt international
68. Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus
    William David Strain, Xavier Cos, Michael Hirst, Sérgio Alberto Cunha Vencio, Viswanathan Mohan, Zoltán Vokó, Daisuke Yabe, Matthias Blüher, Päivi Maria Paldánius · 2014 · Diabetes Research and Clinical Practice
69. Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists
    Tanya Wilcox, Christophe E.M. De Block, Arthur Z. Schwartzbard, Jonathan D. Newman · 2020 · Journal of the American College of Cardiology
70. Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
    Christina L. Aquilante · 2010 · Expert Review of Cardiovascular Therapy
71. The Glycemic Index: Physiological Significance
    Amin Esfahani, Julia MW Wong, Arash Mirrahimi, Korbua Srichaikul, David J.A. Jenkins, Cyril W.C. Kendall · 2009 · Journal of the American College of Nutrition
72. Chinese Guidelines for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2010
    Yongjun Wang, Suming Zhang, Liqun Zhang, Chun‐Xue Wang · 2012 · CNS Neuroscience & Therapeutics
73. The safety and tolerability of GLP‐1 receptor agonists in the treatment of type 2 diabetes: a review
    Vanita R. Aroda, Robert E. Ratner · 2011 · Diabetes/Metabolism Research and Reviews
74. Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
    Sameer Ansar, Juraj Koška, Peter D. Reaven · 2011 · Cardiovascular Diabetology
75. Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials
    Francesco Giorgino, Anna Leonardini, Luigi Laviola · 2013 · Annals of the New York Academy of Sciences
76. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
    Sanjay Kalra, AH Aamir, Abbas Raza, AK Das, AK Azad Khan, Dina Shrestha, MdFaisal Qureshi, Md Fariduddin, Md Faruque Pathan, Fatema Jawad et al. · 2015 · Indian Journal of Endocrinology and Metabolism
77. Glucose targets for preventing diabetic kidney disease and its progression
    Ruospo, Marinella, Saglimbene, Valeria M, Palmer, Suetonia C, De Cosmo, Salvatore, Pacilli, Antonio, Lamacchia, Olga, Cignarelli, Mauro, Fioretto, Paola, Vecchio, Mariacristina, Craig, Jonathan C et al. · 2017 · Cochrane Database of Systematic Reviews
78. Identifying Dysglycemic States in Older Adults: Implications of the Emerging Use of Hemoglobin A1c
    Kasia J. Lipska, Nathalie de Rekeneire, Peter H. Van Ness, Karen Johnson, Alka M. Kanaya, Annemarie Koster, Elsa S. Strotmeyer, Bret H. Goodpaster, Tamara B. Harris, Thomas M. Gill et al. · 2010 · The Journal of Clinical Endocrinology & Metabolism
79. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
    Mahin Chowdhury, Sarah J Nevitt, Aikaterini Eleftheriadou, Prathap Kanagala, Hani Esa, Daniel James Cuthbertson, Abd A. Tahrani, Uazman Alam · 2021 · BMJ Open Diabetes Research & Care
80. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity
    David R. Webb, Kamlesh K. Khunti, R. Silverman, Laura J. Gray, B. T. Srinivasan, Peter S Lacy, Bryan Williams, Melanie Jane Davies · 2010 · Diabetologia
81. Glycemic Control and Burnt‐Out Diabetes in ESRD
    Csaba Pal Kovesdy, Jong Chul Park, Kamyar Kalantar‐Zadeh · 2010 · Seminars in Dialysis
82. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes
    Juuso Blomster, Sophia Zoungas, John Philip Chalmers, Qiang Li, Clara Kayei Chow, Mark Woodward, Giuseppe Mancia, Neil R Poulter, Bryan Williams, Stephen B. Harrap et al. · 2014 · Diabetes Care
83. Fear of hypoglycemia---an underestimated problem
    Przezak, Agnieszka, Bielka, Weronika, Molęda, Piotr · 2022 · Brain and Behavior
84. The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications
    Stéphanie Dal-Ros, S. Sigrist · 2016 · Diseases
85. Glycemic Variability: Risk Factors, Assessment, and Control
    Boris P. Kovatchev · 2019 · Journal of Diabetes Science and Technology
86. Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
    Chang‐Sheng Sheng, Jingyan Tian, Ya Miao, Yi Cheng, Yulin Yang, Peter D. Reaven, Zachary T. Bloomgarden, Guang Ning · 2020 · Diabetes Care
87. Residual microvascular risk in diabetes: unmet needs and future directions
    Paola Fioretto, Paul M Dodson, Dan Ziegler, Robert S. Rosenson · 2009 · Nature Reviews Endocrinology
88. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study
    Elder, Douglas H.J., Singh, Jagdeep S.S., Levin, Daniel, Donnelly, Louise A., Choy, Anna-Maria, George, Jacob, Struthers, Allan D., Doney, Alex S.F., Lang, Chim C. · 2016 · European Journal of Heart Failure
89. Haptoglobin Genotype Is a Consistent Marker of Coronary Heart Disease Risk Among Individuals With Elevated Glycosylated Hemoglobin
    Leah E. Cahill, Andrew P. Levy, Stephanie E. Chiuve, Majken K. Jensen, Hong Wang, Nawar M. Shara, Shany Blum, Barbara V. Howard, Jennifer K. Pai, Kenneth Jay Mukamal et al. · 2013 · Journal of the American College of Cardiology
90. Nuts as a Replacement for Carbohydrates in the Diabetic Diet
    David J.A. Jenkins, Cyril W.C. Kendall, Monica S. Banach, Korbua Srichaikul, Edward Vidgen, Sandy Mitchell, Tina L. Parker, Stephanie K. Nishi, Balachandran Bashyam, Russell J. de Souza et al. · 2011 · Diabetes Care · Retracted
91. Diabetic kidney disease: act now or pay later
    Robert C. Atkins, Paul Zimmet · 2010 · Nature Reviews Nephrology
92. Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans
    Nino Gogitidze Joy, Donna B. Tate, Lisa M. Younk, Stephen N. Davis · 2015 · Diabetes
93. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma
    Tanja Rothhammer-Hampl, Jens Claus Hahne, Alexandra Florin, Ina Poser, Fabrice Soncin, Nicolas Wernert, Anja‐Katrin Bosserhoff · 2004 · Cellular and Molecular Life Sciences
94. Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes
    George David Batty, Qiang Li, Sébastien Czernichow, Bruce Charles Neal, Sophia Zoungas, Rachel Huxley, Anushka A Patel, Bastiaan E. de Galan, Mark Woodward, Pavel Hamet et al. · 2010 · Journal of the American College of Cardiology
95. Comprehensive approach to diabetic nephropathy
    Bancha Satirapoj, Sharon G. Adler · 2014 · Kidney Research and Clinical Practice
96. Prevention of Vascular Cognitive Impairment
    Dichgans, Martin, Zietemann, Vera · 2012 · Stroke
97. New forms of insulin and insulin therapies for the treatment of type 2 diabetes
    Avivit Cahn, Roberto Miccoli, Angela Dardano, Stefano Del Prato · 2015 · The Lancet Diabetes & Endocrinology
98. Novel metabolic biomarkers of cardiovascular disease
    Majken K. Jensen, Monica L. Bertoia, Leah E. Cahill, Isha Agarwal, Eric B. Rimm, Kenneth Jay Mukamal · 2014 · Nature Reviews Endocrinology
99. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
    for the DIGAMI 2 Investigators, Linda Mellbin, Klas Malmberg, Anna Norhammar, Hans Wedel, Lars Rydén · 2011 · Diabetologia
100. Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment
     Andrea Giaccari, Gian Pio Sorice, Giovanna Muscogiuri · 2009 · Nutrition Metabolism and Cardiovascular Diseases